Cellectis (ALCLS) — Capital Reinvestment Ratio

Latest as of June 2024: 0.02x

Cellectis (ALCLS) has a Capital Reinvestment Ratio of 0.02x as of June 2024, meaning it reinvests 0% of its operating cash flow (€52.18 Million) in capital expenditures (€1.04 Million). Check ALCLS intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

€52.18 Million
EUR

Capital Expenditures

€1.04 Million
EUR

Data as of

Jun 2024
Most recent filing

Cellectis Capital Reinvestment Ratio (2005–2024)

This chart tracks Cellectis's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Cellectis.

Annual Capital Reinvestment Ratio for Cellectis (2005–2024)

Year-by-year Capital Reinvestment Ratio for Cellectis from 2005 to 2024. See cash generation quality of Cellectis to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.17x €22.99 Million €3.84 Million ▼ -86.1%
2015 1.20x €3.54 Million €4.25 Million ▲ +14068.8%
2014 0.01x €50.74 Million €430.47K ▼ -98.1%
2008 0.44x €1.78 Million €790.71K ▼ -50.8%
2005 0.90x €391.00K €353.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow